BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 20873127)

  • 1. [Genetically-determined familial recurrent thanatophoric dysplasia].
    Lauda-Swieciak A; Moszczyńska K; Skórczewski J; Ludwikowski G; Szułczyński J; Tretyn A; Dubiel M
    Ginekol Pol; 2010 Aug; 81(8):629-32. PubMed ID: 20873127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal diagnosis of thanatophoric dysplasia in the second trimester: ultrasonography and other diagnostic modalities.
    Sahinoglu Z; Uludogan M; Gurbuz A; Karateke A
    Arch Gynecol Obstet; 2003 Nov; 269(1):57-61. PubMed ID: 14605823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second trimester diagnosis of thanatophoric dysplasia.
    Guu WS; Hsu TT; Chang SY; Chang JC; Huang CC
    Changgeng Yi Xue Za Zhi; 1996 Sep; 19(3):258-63. PubMed ID: 8921645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Thanatoforic dysplasia--case report].
    Pietryga M; Iciek R; Brazert M; Wender-Ozegowska E; Brazert J
    Ginekol Pol; 2010 Jan; 81(1):55-60. PubMed ID: 20232701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second-trimester molecular diagnosis of a heterozygous 742 --> T (R248C) mutation in the FGFR3 gene in a thanatophoric dysplasia variant following suspicious ultrasound findings.
    Chen CP; Chern SR; Wang W; Wang TY
    Ultrasound Obstet Gynecol; 2001 Mar; 17(3):272-3. PubMed ID: 11309183
    [No Abstract]   [Full Text] [Related]  

  • 6. Second trimester molecular diagnosis of a stop codon FGFR3 mutation in a type I thanatophoric dysplasia fetus following abnormal ultrasound findings.
    Chen CP; Chern SR; Chang TY; Lin CJ; Wang W; Tzen CY
    Prenat Diagn; 2002 Aug; 22(8):736-7. PubMed ID: 12210587
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prenatal diagnosis of thanatophoric dysplasia at 21st week of pregnancy].
    Camera G; Dodero D; Camandona F; Camera A
    Pathologica; 1993; 85(1096):215-9. PubMed ID: 8361784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal diagnosis of thanatophoric dwarfism in second trimester. A case report.
    Yüce MA; Yardim T; Kurtul M; Durukan S; Gücer F
    Clin Exp Obstet Gynecol; 1998; 25(4):149-50. PubMed ID: 9987576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prenatal diagnosis of thanatophoric dysplasia at the 20th week of pregnancy using ultrasonography].
    Todros T; Sciarrone A; Voglino G; Botta G; Camera G
    Pathologica; 1995 Dec; 87(6):723-5. PubMed ID: 8927442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasound assessment of biometric trends in a case of thanatophoric dysplasia.
    Fieni S; Gramellini D; Vadora E
    Gynecol Obstet Invest; 2002; 54(2):122-4. PubMed ID: 12566756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and counseling of thanatophoric dysplasia with four-dimensional ultrasound.
    Vasilj O; Mišković B
    J Matern Fetal Neonatal Med; 2012 Dec; 25(12):2786-8. PubMed ID: 22734441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antenatal sonographic diagnosis of thanatophoric dysplasia: a report of three cases and a review of the literature with special emphasis on the differential diagnosis.
    Schild RL; Hunt GH; Moore J; Davies H; Horwell DH
    Ultrasound Obstet Gynecol; 1996 Jul; 8(1):62-7. PubMed ID: 8843623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thanatophoric dysplasia: a case report.
    Jagun OE; Olusola-Bello MA; Adekanmbi AF; Jagun OO; Oduwole T
    Pan Afr Med J; 2020; 37():220. PubMed ID: 33520059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiplex PCR in noninvasive prenatal diagnosis for FGFR3-related disorders.
    Terasawa S; Kato A; Nishizawa H; Kato T; Yoshizawa H; Noda Y; Miyazaki J; Ito M; Sekiya T; Fujii T; Kurahashi H
    Congenit Anom (Kyoto); 2019 Jan; 59(1):4-10. PubMed ID: 29542187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Thanatophoric dysplasia. Its prenatal ultrasonic diagnosis. A case report].
    Marín-Ruiz R; Alarcón Hernandez C; Montiel Ramirez W; González Moreno JM
    Ginecol Obstet Mex; 1993 Dec; 61():344-7. PubMed ID: 8119604
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prenatal diagnosis of thanatophoric dysplasia].
    Szatmáry FP; Szabó L; Tóth T; Kristóf A
    Orv Hetil; 1995 Jan; 136(2):75-8. PubMed ID: 7862435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal diagnosis of thanatophoric dysplasia and obstetrical challenges.
    Bekdache GN; Begum M; Al-Gazali L; Ali BR; Akawi NA; Mirghani H
    J Obstet Gynaecol; 2010; 30(6):628-30. PubMed ID: 20701518
    [No Abstract]   [Full Text] [Related]  

  • 18. Increased first-trimester nuchal translucency associated with thanatophoric dysplasia type 1.
    Zhen L; Pan M; Han J; Yang X; Liao C; Li DZ
    J Obstet Gynaecol; 2015; 35(7):685-7. PubMed ID: 25671245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FGFR3 gene mutations in Chinese cases of thanatophoric dysplasia type 1.
    Yang Y; Li DZ
    Fetal Diagn Ther; 2009; 26(2):90-2. PubMed ID: 19752524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thanatophoric dysplasia.
    Machado LE; Bonilla-Musoles F; Osborne NG
    Ultrasound Obstet Gynecol; 2001 Jul; 18(1):85-6. PubMed ID: 11489235
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.